Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.89-0.62 (-6.52%)
At close: 04:00PM EST
8.89 0.00 (0.00%)
After hours: 06:03PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts2133
Avg. Estimate-0.27-0.3-1.35-1.32
Low estimate-0.3-0.3-1.88-1.6
High estimate-0.25-0.3-0.98-1.1
Year ago EPSN/AN/AN/A-1.35
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts2133
Avg. Estimate2.85M3M10.18M25.4M
Low estimate2.7M3M10MN/A
High estimate3M3M10.53M63M
Year ago salesN/AN/AN/A10.18M
Sales growth (year/est)N/AN/AN/A149.50%
Earnings historyInvalid DateInvalid Date29/06/202129/09/2021
Est. EPSN/AN/A-0.36-0.27
Actual EPSN/AN/A-1.47-0.2
DifferenceN/AN/A-1.110.07
Surprise %N/AN/A-308.30%25.90%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.27-0.3-1.35-1.32
7 days ago-0.27-0.3-1.35-1.32
30 days ago-0.29-0.3-1.43-1.29
60 days ago-0.29-0.3-1.43-1.29
90 days ago-0.29-0.3-1.43-1.29
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A21
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLYELIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next year2.20%N/AN/AN/A
Next 5 years (per annum)-7.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A